Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
FDA regulatory pathway
|
| gptkbp:administeredBy |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:announced |
2024
|
| gptkbp:focus |
rare diseases
serious conditions |
| https://www.w3.org/2000/01/rdf-schema#label |
Accelerate Access Track
|
| gptkbp:purpose |
expedite review of certain medical products
|
| gptkbp:relatedTo |
biologics
drug development rare disease therapies FDA approval process |
| gptkbp:bfsParent |
gptkb:ACCESS_Allocations
|
| gptkbp:bfsLayer |
7
|